Literature DB >> 24115523

Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status.

M Ng Tang Fui1, R Hoermann, A S Cheung, E J Gianatti, J D Zajac, M Grossmann.   

Abstract

Although men with type 2 diabetes (T2D) frequently have lowered testosterone levels, it is not well established whether this is ascribable to the diabetic state per se, or because of other factors, such as obesity. Our objective was to determine the prevalence and correlates of low testosterone in middle-aged men with diabetes. We conducted a cross-sectional study in 240 men including 80 men with type 1 diabetes (T1D), 80 men with T2D and 80 men without diabetes. Prevalence of a total testosterone ≤8 nmol/L was low, occurring in none of the men with T1D, 6.2% of men with T2D and 2.5% of men without diabetes. Men with T1D had higher testosterone levels compared with men without diabetes (p < 0.001), even after adjustment for body mass index (BMI) and age (p < 0.02). While men with T2D had lower testosterone compared with controls (p = 0.03), this was no longer significant when BMI and age were taken into account (p = 0.16). In the entire cohort, TT remained inversely associated with BMI independent of age, sex hormone-binding globulin and diabetic status (p = 0.01), whereas calculated free testosterone (cFT) was independently and inversely associated with age (p < 0.001), but not with BMI (p = 0.47). These results suggest that marked reductions in circulating testosterone are uncommon in middle-aged men with diabetes. Increasing BMI and age are dominant drivers of lowered total and cFT, respectively, independent of the presence or absence of diabetes.
© 2013 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  ageing; diabetes; obesity; testosterone

Mesh:

Substances:

Year:  2013        PMID: 24115523     DOI: 10.1111/j.2047-2927.2013.00124.x

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  11 in total

1.  Effects of testosterone supplement treatment in hypogonadal adult males with T2DM: a meta-analysis and systematic review.

Authors:  Jianzhong Zhang; Bin Yang; Wenhui Xiao; Xiao Li; Hongjun Li
Journal:  World J Urol       Date:  2018-03-06       Impact factor: 4.226

2.  The implications of low testosterone on mortality in men.

Authors:  Molly M Shores
Journal:  Curr Sex Health Rep       Date:  2014-12-01

3.  The association of obesity with sex hormone-binding globulin is stronger than the association with ageing--implications for the interpretation of total testosterone measurements.

Authors:  Lori A Cooper; Stephanie T Page; John K Amory; Bradley D Anawalt; Alvin M Matsumoto
Journal:  Clin Endocrinol (Oxf)       Date:  2015-05-11       Impact factor: 3.478

4.  Cognitive response to testosterone replacement added to intensive lifestyle intervention in older men with obesity and hypogonadism: prespecified secondary analyses of a randomized clinical trial.

Authors:  Giulia Gregori; Alessandra Celli; Yoann Barnouin; Arjun Paudyal; Reina Armamento-Villareal; Nicola Napoli; Clifford Qualls; Dennis T Villareal
Journal:  Am J Clin Nutr       Date:  2021-11-08       Impact factor: 8.472

Review 5.  The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

Authors:  Marià Alemany
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

6.  Serum sex hormone levels in different severity of male adult obstructive sleep apnea-hypopnea syndrome in East Asians.

Authors:  Jia-Qi Dong; Xiong Chen; Ying Xiao; Rui Zhang; Xun Niu; Wei-Jia Kong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31

Review 7.  Testosterone, aging and survival: biomarker or deficiency.

Authors:  Molly M Shores; Alvin M Matsumoto
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-06       Impact factor: 3.243

8.  Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: findings from the DCCT/EDIC.

Authors:  Sarah K Holt; Natalya Lopushnyan; James Hotaling; Aruna V Sarma; Rodney L Dunn; Patricia A Cleary; Barbara H Braffett; Patricia Gatcomb; Catherine Martin; William H Herman; Hunter Wessells
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

9.  Effects of intraperitoneal insulin versus subcutaneous insulin administration on sex hormone-binding globulin concentrations in patients with type 1 diabetes mellitus.

Authors:  M Boering; P R van Dijk; S J J Logtenberg; K H Groenier; B H R Wolffenbuttel; R O B Gans; N Kleefstra; H J G Bilo
Journal:  Endocr Connect       Date:  2016-05       Impact factor: 3.335

10.  Impact of Metabolic Syndrome Factors on Testosterone and SHBG in Type 2 Diabetes Mellitus and Metabolic Syndrome.

Authors:  Mukhtar Mohammed; Molham Al-Habori; Ahmed Abdullateef; Riyadh Saif-Ali
Journal:  J Diabetes Res       Date:  2018-07-02       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.